{
    "clinical_study": {
        "@rank": "6382", 
        "arm_group": {
            "arm_group_label": "Standard mode of controlled ventilation", 
            "arm_group_type": "Experimental", 
            "description": "Each brain injured patient will be ventilated during two hours with a standard mode of controlled ventilation."
        }, 
        "brief_summary": {
            "textblock": "Comparison of the ability of a new automated ventilatory mode named Intellibrain to maintain\n      capnia and oxgen partial pressure within predefined ranges in comparison to the control of\n      capnia and oxgen partial pressure obtained by using standard controlled ventilation modes in\n      brain injured patients. Comparison of the numbers of alarms and required settings\n      modifications observed with each ventilatory mode."
        }, 
        "brief_title": "Comparison of a New Automated Ventilatory Mode Named Intellivent to Standard Controlled Ventilation in Brain Injured Patients", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Brain Injured Patients", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Brain injury ( traumatic brain injury, subarachnoi8dal haemorrhage, intracerebral\n             hemorrhage, ischemic stroke)\n\n          -  Glasgow coma scale of 9 or less\n\n          -  Controlled mechanical ventilation required\n\n          -  Intracranial pressure monitoring required for clinical reasons\n\n        Exclusion Criteria:\n\n          -  age under 16 years old\n\n          -  clinical signs of brainstem lesions\n\n          -  patients with withdrawal order or for whom organ donation is under discussion\n\n          -  major haemodynamic instability\n\n          -  High carbon dioxide alveoloarterial gradient (>10 mmHg) and/or suffering of severe\n             hypoxemia (PaO2/FIO2 < 150 mmHg)\n\n          -  Patients included in another interventional clinical study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": {
            "#text": "23", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01695603", 
            "org_study_id": "Intellibrain"
        }, 
        "intervention": {
            "arm_group_label": "Standard mode of controlled ventilation", 
            "description": "Two hours of ventilation will be delivered with the Intellivent automated mode and will be compared to two hours during usual controlled ventilation.", 
            "intervention_name": "Intellivent", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Brain injury", 
            "Controlled ventilation", 
            "Intellivent", 
            "Capnia control"
        ], 
        "lastchanged_date": "May 23, 2013", 
        "location": {
            "contact": {
                "email": "philippe.jolliet@chuv.ch", 
                "last_name": "Philippe Jolliet, Professor", 
                "phone": "+41 79 556 16 50"
            }, 
            "contact_backup": {
                "email": "lise.piquilloud@chuv.ch", 
                "last_name": "Lise Piquilloud, MD", 
                "phone": "+4179 556 76 42"
            }, 
            "facility": {
                "address": {
                    "city": "Lausanne", 
                    "country": "Switzerland", 
                    "zip": "1012"
                }, 
                "name": "Adult Intensive Care and Burn Unit, University hospital of Lausanne"
            }, 
            "investigator": [
                {
                    "last_name": "Philippe Jolliet, Professor", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Lise Piquilloud, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Jean-Pierre Revelly, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "1", 
        "official_title": "Comparison of a New Automated Ventilatory Mode Named Intellivent to Standard Controlled Ventilation in Brain Injured Patients", 
        "overall_contact": {
            "email": "philippe.jolliet@chuv.ch", 
            "last_name": "Philippe Jolliet, Prof", 
            "phone": "+41 79 556 16 50"
        }, 
        "overall_contact_backup": {
            "email": "lise.piquilloud@chuv.ch", 
            "last_name": "Lise Piquilloud, MD", 
            "phone": "+4179 556 76 42"
        }, 
        "overall_official": {
            "affiliation": "University of Lausanne Hospitals", 
            "last_name": "Philippe Jolliet, Prof", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Switzerland: Ethikkommission", 
                "Switzerland: Laws and standards"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The partial pressure of carbon dioxide (PaCO2) will be recorded every thirty minutes during 2 hours under standard controlled ventilation and during 2 hours under Intellivent ventilation", 
            "measure": "Partial pressure of carbon dioxide", 
            "safety_issue": "No"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01695603"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Lausanne Hospitals", 
            "investigator_full_name": "Prof. Philippe Jolliet", 
            "investigator_title": "Main investigator", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The partial pressure of oxygen (PaCO2) will be recorded every thirty minutes during 2 hours under standard controlled ventilation and during 2 hours under Intellivent ventilation", 
                "measure": "Partial pressure of oxygen", 
                "safety_issue": "No"
            }, 
            {
                "description": "The number of alarms generated by the ventilator will be recorded during 2 hours under standard controlled ventilation and during 2 hours under Intellivent ventilation", 
                "measure": "Number of alarms generated by the ventilator", 
                "safety_issue": "No"
            }, 
            {
                "description": "The number of ventilator settings modifications required will be recorded during 2 hours under standard controlled ventilation and during 2 hours under Intellivent ventilation", 
                "measure": "Number of settings modifications", 
                "safety_issue": "No"
            }, 
            {
                "description": "Intracranial pressure will be recorded continuously during 2 hours under standard controlled ventilation and during 2 hours under Intellivent ventilation", 
                "measure": "Intracranial pressure", 
                "safety_issue": "No"
            }, 
            {
                "description": "Various respiratory parameters tidal volume, respiratory rate, minute ventilation, airway pressure) will be recorded during 2 hours under standard controlled ventilation and during 2 hours under Intellivent ventilation", 
                "measure": "Respiratory parameters", 
                "safety_issue": "No"
            }, 
            {
                "description": "Cerebral vasoreactivity will be studied from the intracranial pressure and invasive arterial pressure curves recorded  during 2 hours under standard controlled ventilation and during 2 hours under Intellivent ventilation", 
                "measure": "Cerebral vasoreactivity", 
                "safety_issue": "No"
            }, 
            {
                "description": "Partial pressure of oxygen in the brain tissue, if available for clinical reasons, will be recorded during 2 hours under standard controlled ventilation and during 2 hours under Intellivent ventilation", 
                "measure": "Partial pressure of oxygen in the brain tissue if available", 
                "safety_issue": "No"
            }, 
            {
                "description": "The number of therapeutic actions needed to reduce intracranial pressure will be recorded during two hours under standard controlled ventilation and during two hours under Intellivent ventilation.", 
                "measure": "Number of therapeutic actions needed to reduce intracranial pressure", 
                "safety_issue": "No"
            }, 
            {
                "description": "Cerebral perfusion pressure will be recorded continuously during 2 hours under standard controlled ventilation and during 2 hours under Intellivent ventilation", 
                "measure": "Cerebral perfusion pressure", 
                "safety_issue": "No"
            }
        ], 
        "source": "University of Lausanne Hospitals", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Lausanne Hospitals", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Prof. Philippe Jolliet", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}